Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prion

Showing results (1-10 of 717) with videos related to

Pageof 72
Sort By:
Prion|November 9, 2010
The toxicity of an "artificial" amyloid is related to how it interacts with membranesJulien Couthouis, Christelle Marchal, Fabien D'Angelo, et al.
Prion|December 18, 2010
Dementia screening, biomarkers and protein misfolding: Implications for public health and diagnosisJames E Galvin
Prion|December 8, 2010
Implications of the prion-related Q/N domains in TDP-43 and FUSMaria Udan, Robert H Baloh
Prion|August 21, 2010
Nanoimaging for prion related diseasesAlexey V Krasnoslobodtsev, Alexander M Portillo, Tanja Deckert-Gaudig, et al.
Prion|July 13, 2010
Cell-based immunotherapy of prion diseases by adoptive transfer of antigen-loaded dendritic cells or antigen-primed CD(4+) T lymphocytesClaude Carnaud, Véronique Bachy
Prion|September 25, 2010
Structural requirements for efficient prion protein conversion: cofactors may promote a conversion-competent structure for PrP(C)Andrew C Gill, Sonya Agarwal, Teresa J T Pinheiro, et al.
Prion|October 16, 2010
Nucleic acid-free mutation of prion strainsGlenn C Telling
Prion|January 23, 2009
Amyloid fibrils: abnormal protein assemblyRoma N Rambaran, Louise C Serpell
Prion|January 23, 2009
Antagonistic roles of the N-terminal domain of prion protein to doppelSuehiro Sakaguchi
Prion|January 24, 2009
Prions and related phenomenaYury O Chernoff
Pageof 72

Showing results (1-10 of 717) with videos related to

Sort By:
Pageof 72
Prion|November 9, 2010
The toxicity of an "artificial" amyloid is related to how it interacts with membranesJulien Couthouis, Christelle Marchal, Fabien D'Angelo, et al.
Prion|December 18, 2010
Dementia screening, biomarkers and protein misfolding: Implications for public health and diagnosisJames E Galvin
Prion|December 8, 2010
Implications of the prion-related Q/N domains in TDP-43 and FUSMaria Udan, Robert H Baloh
Prion|August 21, 2010
Nanoimaging for prion related diseasesAlexey V Krasnoslobodtsev, Alexander M Portillo, Tanja Deckert-Gaudig, et al.
Prion|July 13, 2010
Cell-based immunotherapy of prion diseases by adoptive transfer of antigen-loaded dendritic cells or antigen-primed CD(4+) T lymphocytesClaude Carnaud, Véronique Bachy
Prion|September 25, 2010
Structural requirements for efficient prion protein conversion: cofactors may promote a conversion-competent structure for PrP(C)Andrew C Gill, Sonya Agarwal, Teresa J T Pinheiro, et al.
Prion|October 16, 2010
Nucleic acid-free mutation of prion strainsGlenn C Telling
Prion|January 23, 2009
Amyloid fibrils: abnormal protein assemblyRoma N Rambaran, Louise C Serpell
Prion|January 23, 2009
Antagonistic roles of the N-terminal domain of prion protein to doppelSuehiro Sakaguchi
Prion|January 24, 2009
Prions and related phenomenaYury O Chernoff
Pageof 72